Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
iShares Core S&P Small-Cap ETF
IJR
$109B
| $32.1M | 0.02% |
+470,361
| New | +$29.7M |
|
852
Encompass Health
EHC
$11B
| $32M | 0.02% |
649,850
+16,008
| +3% | +$864K |
|
853
Ingredion
INGR
$6.27B
| $32M | 0.02% |
385,477
-5,373
| -1% | -$440K |
|
|
WORK
854
DELISTED
Slack Technologies, Inc.
WORK
| $31.8M | 0.02% |
1,023,467
+120,660
| +13% | +$3.63M |
|
855
GSK
GSK
$104B
| $31.8M | 0.02% |
624,000
-48,000
| -7% | -$2.46M |
|
856
International Bancshares
IBOC
$4.76B
| $31.8M | 0.02% |
992,377
+385,188
| +63% | +$11.1M |
|
|
UNIT
857
Uniti Group
UNIT
$2.36B
| $31.7M | 0.02% |
3,390,734
+566,548
| +20% | +$4.25M |
|
858
iShares CMBS ETF
CMBS
$474M
| $31.6M | 0.02% |
575,878
-17,021
| -3% | -$917K |
|
859
B&G Foods
BGS
$287M
| $31.5M | 0.02% |
1,293,814
+170,410
| +15% | +$3.69M |
|
|
CCMP
860
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $31.5M | 0.02% |
225,851
+3,538
| +2% | +$458K |
|
861
Mercury Systems
MRCY
$5.83B
| $31.5M | 0.02% |
400,634
-89,040
| -18% | -$7.29M |
|
862
Arrowhead Research
ARWR
$11.9B
| $31.5M | 0.02% |
729,508
+26,482
| +4% | +$935K |
|
|
TECD
863
DELISTED
Tech Data Corp
TECD
| $31.4M | 0.02% |
216,730
-87,143
| -29% | -$12M |
|
864
American Airlines Group
AAL
$10.1B
| $31.4M | 0.02% |
2,401,826
+519,556
| +28% | +$6.3M |
|
865
Darling Ingredients
DAR
$9.64B
| $31.4M | 0.02% |
1,274,063
+75,777
| +6% | +$1.65M |
|
866
Medpace
MEDP
$16.1B
| $31.1M | 0.02% |
334,827
+80,819
| +32% | +$6.88M |
|
867
Armstrong World Industries
AWI
$7.38B
| $31.1M | 0.02% |
399,062
+2,742
| +0.7% | +$208K |
|
|
WRI
868
DELISTED
Weingarten Realty Investors
WRI
| $31M | 0.02% |
1,640,157
-574,861
| -26% | -$10.1M |
|
869
Jabil
JBL
$33B
| $31M | 0.02% |
966,985
-26,959
| -3% | -$776K |
|
|
PFPT
870
DELISTED
Proofpoint, Inc.
PFPT
| $31M | 0.02% |
278,581
+9,613
| +4% | +$1.1M |
|
871
Evercore
EVR
$12.4B
| $30.9M | 0.02% |
525,264
+137,883
| +36% | +$7.5M |
|
|
PCH
872
DELISTED
PotlatchDeltic
PCH
| $30.9M | 0.02% |
813,141
+282,154
| +53% | +$9.54M |
|
|
BERY
873
DELISTED
Berry Global Group, Inc.
BERY
| $30.9M | 0.02% |
759,736
+5,208
| +0.7% | +$196K |
|
874
Mattel
MAT
$4.38B
| $30.8M | 0.02% |
3,189,579
+30,801
| +1% | +$280K |
|
875
KBR
KBR
$4.62B
| $30.8M | 0.02% |
1,366,197
-34,173
| -2% | -$743K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.